New Submissions Are Not Currently Being Accepted
Samples sent after April 10, 2024 will be put on hold.
Viewing desktop version: Switch to Mobile
ID: 1741
Result Photo
Test Date: May 01, 2008
Pub. Date: Aug 26, 2009
Src Location:
Submitter Loc: ----, --
United States
Color: Yellow
Size: -
Data Source: DEA
Tested by: DEA
Lab's ID: 080500_01
The DEA Mid-Atlantic Laboratory (Largo, Maryland) recently received 705 yellow tablets with a Superman logo, suspected MDMA. The exhibits were seized at a mail distribution facility in Norfolk, Virginia by the Norfolk Police. Analysis of the tablets (total net mass 198.1 grams) by GC/MS, TLC, and GC confirmed MDMA (10.9 milligrams/tablet), adulterated with methamphetamine (6.1 milligrams/tablet), N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)-piperazine (TFMPP), dibenzylpiperazine, caffeine, and procaine. The three piperazines were not quantitated; however, based on the TIC and GC, the BZP and TFMPP were both higher in concentration than the MDMA and methamphetamine. The tablets also contained MDP2P and piperonal (both indicative of the MDMA synthesis route). The Mid-Atlantic Laboratory has seen a wide variety of Ecstasy combination tablets containing both MDMA and methamphetamine, and a few Ecstasy-mimic tablets containing BZP and TFMPP mixtures, but this is believed to be the first such submission containing all four of these drugs.